Ingrid P. Buchler

Novel tetrahydro-β-carboline-1-carboxylic acids as inhibitors of mitogen activated protein kinase-activated protein kinase 2 (MK-2)

John I. Trujillo, Marvin J. Meyers, David R. Anderson et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 136 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Pharmaceutical Chemistry +10

Evidence for Separate Binding and Scaffolding Domains in the Immunosuppressive and Antitumor Marine Natural Product, Pateamine A:  Design, Synthesis, and Activity Studies Leading to a Potent Simplified Derivative

Daniel Romo, Nam Song Choi, Shukun Li et al. · Journal of the American Chemical Society · 2004 · 82 citations

Promyelinating drugs promote functional recovery in an autism spectrum disorder mouse model of Pitt–Hopkins syndrome

Joseph F. Bohlen, Colin Cleary, Debamitra Das et al. · Brain · 2023 · 33 citations · Full text

Aminopyrazole Carboxamide Bruton’s Tyrosine Kinase Inhibitors. Irreversible to Reversible Covalent Reactive Group Tuning

Mark E. Schnute, Stephen Benoit, Ingrid P. Buchler et al. · ACS Medicinal Chemistry Letters · 2018 · 27 citations · Full text

Pharmaceutical Science, Tyrosine Kinase, Pharmacotherapy +16

Development of a PC12 Cell Based Assay for Screening Catechol- <i>O</i> -methyltransferase Inhibitors

Gongliang Zhang, Ingrid P. Buchler, Michael DePasquale et al. · ACS Chemical Neuroscience · 2019 · 23 citations · Full text